Nishan M DeSilva
CIK 1492386 · VP, Finance & Strategy and CFO · last filed 2026-01-06
Nishan M DeSilva is a VP, Finance & Strategy and CFO who has filed 19 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing, for RNAC, was dated Jan 6, 2026. Across all open-market trades the lifetime net is −$5.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.80M
4
19
-$5.84M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNAC | Director | 11,366 | $9.51 | $108.1K | $0 | 4 | 2026-01-06 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | 7,000 | $0.88 | $6.2K | $20.7K | 4 | 2023-01-04 |
| LGND | VP, Finance & Strategy and CFO | 22,282 | $255.54 | $5.69M | -$5.86M | 7 | 2015-05-14 |
| ALLOS THERAPEUTICS INC (ALTH) Delisted | Director | 35,000 | — | — | $0 | 2 | 2011-12-15 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | RNAC | Grant (A) | +2,600 | $0 | EDGAR |
| 2025-01-06 | RNAC | Grant (A) | +2,600 | $0 | EDGAR |
| 2024-01-04 | RNAC | Grant (A) | +178,000 | $0 | EDGAR |
| 2023-11-15 | RNAC | Disp (D) | — | $0 | EDGAR |
| 2023-01-04 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-06 | Cartesian Therapeutics, Inc. (SELB) Delisted | Buy (P) | +7,000 | $20.7K | EDGAR |
| 2021-07-09 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-14 | LGND | Mixed | — | -$3.33M | EDGAR |
| 2015-02-11 | LGND | Mixed | +3,623 | -$129.6K | EDGAR |